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Abstract: Circulating uric acid concentrations have been linked to various metabolic diseases.
Consumption of large boluses of nucleotides increases serum uric acid concentrations. We investigated
the effect of a nucleotide-rich mixed meal on postprandial circulating uric acid, glucose, and insulin
responses. Ten healthy adults participated in a randomised, controlled, double-blind, crossover trial
in which they consumed a mixed-meal containing either nucleotide-depleted mycoprotein (L-NU)
or high-nucleotide mycoprotein (H-NU) on two separate visits. Blood samples were collected in
the postabsorptive state and throughout a 24 h postprandial period, and were used to determine
circulating uric acid, glucose, and insulin concentrations. Mixed meal ingestion had divergent
effects on serum uric acid concentrations across conditions (time x condition interaction; P < 0.001),
with L-NU decreasing transiently (from 45 to 240 min postprandially) by ~7% (from 279 ± 16 to
257 ± 14 µmol·L−1) and H-NU resulting in a ~12% increase (from 284 ± 13 to 319 ± 12 µmol·L−1 after
210 min), remaining elevated for 12 h and returning to baseline concentrations after 24 h. There were
no differences between conditions in blood glucose or serum insulin responses, nor in indices of insulin
sensitivity. The ingestion of a nucleotide-rich mixed-meal increases serum uric acid concentrations
for ~12 h, but does not influence postprandial blood glucose or serum insulin concentrations.
Keywords: nucleotides; serum uric acid; metabolic health; mycoprotein
1. Introduction
Free ribonucleic acid (RNA) naturally occurs to varying degrees in many dietary protein sources.
Upon ingestion, RNA is digested and absorbed as its constituent nitrogenous nucleotide bases
(pyrimidines and purines), pentose sugars and phosphate ions. The primary end-product of purine
metabolism is uric acid, which is mainly formed in the liver, transported to the kidneys and excreted in
urine [1]. Human consumption of large boluses (>2 g/day) of isolated or (single-cell) yeast derived
nucleotides has been shown to result in acute increases in circulating uric acid concentrations [2–4].
Epidemiological and observational data have reported that circulating uric acid concentrations
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positively correlate with development of gout [5], hypertension [6], and metabolic syndrome [7],
and are a predictor of type 2 diabetes [8], though causation (particularly by diet) has not been
established. Nevertheless, these findings informed the FAO/WHO/UNICEF (Food and Agriculture
Organization/ World Health Organization/United Nations Children’s Fund). Protein Advisory Group
recommendation to limit the additional dietary nucleic acid load from single cell protein novel foods
to no more than 2 g/day [9,10]. How this translates to practical nutrition is unclear, since the ingestion
of a high nucleotide containing mixed meal upon circulating uric acid concentrations has not been
investigated. Moreover, whether acute elevations of serum uric acid influence, and therefore may be
causatively linked to, markers of metabolic health, such as postprandial insulin sensitivity or glucose
tolerance, is also unknown.
Mycoprotein is a single celled fungal-derived protein rich food source produced by the continuous
cultivation of Fusarium venenatum and is naturally rich in RNA-derived nucleotides. To comply
with the FAO/WHO/UNICEF Protein Advisory Group recommendations, industrial production of
mycoprotein for commercial use involves the reduction of RNA content from ~10% to ~2% of its
dry weight. This is achieved by an industrially expensive process of subjecting the culture broth
to a short heat treatment (68 ◦C, 20 min) following fermentation, which allows for (endogenous)
enzymatic breakdown of nucleotides, without affecting protein content [11]. We have previously
shown that this process is effective, since the ingestion of nucleotide depleted mycoprotein up to
quantities of 40 g did not influence postprandial circulating uric acid concentrations [12], with even 60 g
causing only a transient (~2 h) and modest (from ~350 to ~380 µmol·L−1; well below clinically relevant
thresholds of >420 µmol·L−1 [13]) rise, and in line with the consumption of other protein sources [14].
However, it is not known what impact the ingestion of non-nucleotide depleted mycoprotein has
upon the postprandial serum uric acid response. By obtaining nucleotide depleted and non-depleted
mycoprotein containing food products, we were able to test the hypothesis that the ingestion of a single
nucleotide-rich mixed meal would acutely increase circulating uric acid concentrations and impair
postprandial glucose handling.
2. Materials and Methods
2.1. Participants and Medical Screening
Ten healthy young adults (age: 25 ± 1 years; BMI: 24.4 ± 1.0 kg/m2; male = 4 and female = 6)
participated in the present study. Participants’ characteristics are presented in Table 1. Prior to
participating, each subject attended a screening visit to ensure eligibility. Blood pressure, body mass,
height, and body composition (determined by air displacement plethysmography: Bodpod; Life
Measurement, Inc., Concord, CA, USA) were measured at screening. Smokers and participants taking
regular medication or suffering from chronic diseases were excluded. Participants included were
recreationally active (partook in regular exercise or sport at a non-competitive level, two to five days
a week), normotensive, and had a BMI between 18.5 and 30 kg/m2. All participants were informed
of the study’s purposes, procedures and risks, and provided written informed consent. The study
was approved by the University of Exeter’s Sport and Health Sciences Ethics Committee (Ref No:
170712/A/01) in accordance with the Declaration of Helsinki, and was registered at ClinicalTrials.gov
(NCT03568864) following the Consolidated Standards of Reporting Trials (CONSORT; Table S1 and
Figure S1).
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Table 1. Participants’ characteristics.
Sex 6 female/4 male
Age (years) 25 ± 1
Height (cm) 171 ± 3
Body mass (kg) 72 ± 4
Body mass index (kg/m2) 24.4 ± 1.0
Body fat (% of body mass) 22 ± 4
Lean mass (kg) 57 ± 5
Systolic blood pressure (mmHg) 117 ± 5
Diastolic blood pressure (mmHg) 68 ± 2
2.2. Experimental Protocol
The present study was a randomised, controlled, double-blind, crossover trial, where participants
consumed a meal containing either a low (L-NU) or high (H-NU) amount of dietary nucleotides (1.96%
and 8.83% of the mycoprotein (dry weight) in L-NU and H-NU, respectively; Table 2 details full
nutritional composition of the test meals).
Table 2. Nutritional composition of the experimental meals.
L-NU H-NU
Energy and macronutrients
Energy (kJ) 2519 2519
Energy (kcal) 602 602
Protein (g) 28 28
Carbohydrate (g) 58 58
Fat (g) 26 26
Nucleotides (in dry mycoprotein)
CMP (g/%) - 0.12/0.62
UMP (g/%) 0.05/0.26 0.08/0.44
GMP (g/%) 0.04/0.21 0.05/0.28
TMP (g/%) 0.09/0.46 0.57/3.00
CDP (g/%) 0.04/0.19 0.16/0.84
UDP (g/%) 0.01/0.07 0.06/0.34
CTP (g/%) 0.09/0.47 0.60/3.18
ADP (g/%) 0.00/0.02 0.02/0.08
TTP (g/%) - 0.01/0.04
ITP (g/%) 0.06/0.29 -
ATP (g/%) - 0.00/0.01
Total nucleotides (g/%) 0.38/1.96 1.70/8.83
Abbreviations: L-NU, Low nucleotide condition; H-NU, High nucleotide condition; CMP, Cytidine monophosphate;
UMP, Uridine monophosphate; GMP, Guanosine monophosphate; TMP, Thymidine monophosphate; CDP, Cytidine
diphosphate; UDP, Uridine diphosphate; CTP, Cytidine triphosphate; ADP, Adenosine diphosphate; TTP, Thymidine
triphosphate; ITP, Inosine triphosphate; ATP, Adenosine triphosphate.
Participants reported to the laboratory at ~08.00 a.m., after an overnight fast and refraining from
intense exercise and alcohol consumption for at least 24 h, to undertake two identical experimental test
days, separated by a two-week washout period. A cannula was placed retrogradely in a dorsal hand
vein and the hand was then placed in a heated box (55 ◦C) for arterialised-venous blood sampling [15].
A fasted baseline arterialised-venous blood sample was collected and participants ingested the test
meal, consisting of a sandwich made of three slices of bread (132 g; Kingsmill 50/50 medium, Allied
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Bakeries, UK), two packets of mayonnaise (28 g; Hellmann’s, Unilever, United States) and eight Quorn
vegetarian chicken slices (100 g; Quorn, Marlow Foods, UK), containing either the nucleotide-depleted
(L-NU) mycoprotein or the nucleotide-rich (H-NU) mycoprotein (77 g wet weight; corresponding to
19 g dry weight) in 10 min or less (with the exact time being recorded for each participant in the first
visit and replicated on the second experimental test day). Arterialised-venous blood samples were
then collected for a 4 h postprandial period, at 15 min intervals for the first hour and at 30 min intervals
subsequently. Afterwards, participants were allowed to leave the laboratory and were instructed to
return at 8, 12, and 24 h after the ingestion of the sandwich for further (venous) blood sample collection
via venepuncture. Participants kept a diary detailing their food intake and physical activity during the
24 h period of the first experimental visit and replicated this for the second experimental visit.
2.3. Plasma and Serum Collection and Analyses
One mL of each blood sample was collected into FX blood collection tubes (Becton Dickinson,
Franklin Lakes, NJ, USA) and glucose was immediately analysed using the YSI 2300 STAT PLUS
Biochemistry Analyser (YSI, Yellow Springs, OH, USA). Four mL of each blood sample was collected
into SST tubes (Becton Dickinson, Franklin Lakes, NJ, USA) and left at room temperature for at
least 30 min to clot, before being centrifuged at 4 ◦C and 4000 RPM. The aliquoted serum samples
were analysed for uric acid concentrations using the Roche Cobas 702 module of the Cobas 8000
analyser (Roche, Basel, Switzerland) and Roche Uric Acid Kits (Cobas; UA2) in the Clinical Chemistry
department of the Royal Devon and Exeter NHS Foundation Trust. Serum insulin concentrations were
analysed using DRG ELISA kits (DRG International, Springfield, NJ, USA). An adapted Cederholm
insulin sensitivity index (Cederholm ISI; accounting for the carbohydrate intake from the mixed meal)
was calculated using the blood glucose and serum insulin concentrations measured in the fasting state
and during the 4 h post-prandial period, to provide an indirect measure of peripheral insulin sensitivity.
2.4. Statistical Analyses
All data are expressed as means ± standard errors (SEM). Serum uric acid, blood glucose,
and serum insulin concentrations were analysed using two-way ANOVAs (with condition and time as
factors). Bonferroni post hoc tests were performed in the event of significant main effects. Additionally,
incremental Area Under the Curves (iAUCs) were calculated for blood glucose and serum insulin,
and paired t-tests were performed to detect any significant effect of condition. The adapted Cederholm
ISI data were also analysed using a paired t-test.
3. Results
3.1. Serum Uric Acid
Serum uric acid concentrations during the 24 h experimental period are reported in
Figure 1. Baseline fasting serum uric acid concentrations were not different between conditions
(274 ± 16 µmol·L−1 in L-NU and 284 ± 13 µmol·L−1 in H-NU; P > 0.05). Meal ingestion influenced
serum uric acid concentrations (effect of time; P < 0.001) and it did so divergently between groups
(time x condition interaction; P < 0.001). In L-NU, meal ingestion modestly (~7 %) and transiently
(from 45 min (279 ± 16 µmol·L−1) to 4 h (257 ± 14 µmol·L−1) post meal consumption) decreased serum
uric acid concentrations, with baseline levels restored by 8 h post meal ingestion. Conversely, in the
H-NU condition, following meal ingestion serum uric acid concentrations rose steadily by ~12 %,
peaking after 210 min (319 ± 12 µmol·L−1; P < 0.05), remaining elevated for 12 h and returning to
baseline concentrations only after 24 h (302 ± 13 µmol·L−1; P > 0.05).
Nutrients 2020, 12, 1115 5 of 9
Nutrients 2020, 12, x FOR PEER REVIEW 5 of 9 
 
Figure 1. Temporal response of serum uric acid concentrations during a 24 h period following the 
consumption of a nucleotide-depleted (L-NU) or nucleotide-rich (H-NU) mycoprotein-based mixed 
meal in healthy young adults (n = 10). Data were analysed using a two-way ANOVA and Bonferroni 
post-hoc tests. Values are means with SEM represented by vertical bars. Main effect of time (P < 0.01), 
condition (P > 0.05) and time x condition interaction (P < 0.0001). * denotes significantly different from 
corresponding baseline value. 
When looking at sex based differences, postabsorptive serum uric acid concentrations were 
higher in male compared with female participants (314 ± 13 and 264 ± 14 µmol.L−1, respectively; P < 
0.05). Meal ingestion influenced serum uric acid concentrations similarly across sexes and in line with 
the cohort as a whole (effect of time, P < 0.0001; trend for a time x condition interaction, P = 0.07) with 
similar absolute rises of ~30 to 40 µmol.L−1 (peaking after 210 min at 345 ± 11 µmol.L−1 for males and 
after ~8 h at 305 ± 14 µmol.L−1 for females), though this represented seemingly, but not significantly, 
differing rises expressed as a percentage across sexes (9 ± 2 and 16 ± 4 % for males and females, 
respectively; P > 0.05). In addition, females displayed more persistent elevations of serum uric acid 
concentrations with 24 h not being sufficient to return to baseline levels (after ~ 24 h: 292 ± 21 
µmol.L−1). 
3.2. Blood Glucose and Serum Insulin 
Temporal blood glucose and serum insulin concentrations for the 4 h post prandial period are 
displayed in Figure 2A,C. Fasting blood glucose and serum insulin concentrations did not differ 
between conditions at baseline (both P > 0.05). For both measures, there was a significant effect of 
time (P < 0.0001), such that meal ingestion increased blood glucose and serum insulin concentrations 
(peaking at 30 min; glucose: 6.2 ± 0.2 and 6.1 ± 0.2 mmol.L−1, and insulin: 67 ± 10 and 63 ± 8 mU.L−1, for 
L-NU and H-NU, respectively) and to a similar degree for both conditions (condition and time x 
condition interaction; P > 0.05). Blood glucose iAUC and serum insulin iAUC during the OGTT 
(displayed in Figure 2B,D) were also not different between conditions (P > 0.05). Consequently, 
indirect peripheral insulin sensitivity calculated using the adapted Cederholm ISI did not differ 
between conditions (61 ± 3 and 64 ± 3 mg·L2·mmol−1·mU−1·min−1 for L-NU and H-NU, respectively; P 
> 0.05). 
Figure 1. Temporal response of serum uric acid concentrations during a 24 h period following the
consumption of a nucleotide-depleted (L-NU) or nucleotide-rich (H-NU) mycoprotein-based mixed
meal in healthy young adults (n = 10). Data were analysed using a two-way ANOVA and Bonferroni
post-hoc tests. Values are means with SEM represented by vertical bars. Main effect of time (P < 0.01),
condition (P > 0.05) and time x condition interaction (P < 0.0001). * denotes significantly different from
corresponding baseline value.
When looking at sex based differences, postabsorptive serum uric acid concentrations were higher
in male compared with female participants (314 ± 13 and 264 ± 14 µmol·L−1, respectively; P < 0.05).
Meal ingestion influenced serum uric acid concentrations similarly across sexes and in line with the
cohort as a whole (effect of time, P < 0.0001; trend for a time x condition interaction, P = 0.07) with
similar absolute rises of ~30 to 40 µmol·L−1 (peaking after 210 min at 345 ± 11 µmol·L−1 for males and
after ~8 h at 305 ± 14 µmol·L−1 for females), though this represented seemingly, but not significantly,
differing rises expressed as a percentage across sexes (9 ± 2 and 16 ± 4 % for males and females,
respectively; P > 0.05). In addition, females displayed more persistent elevations of serum uric acid
concentrations with 24 h not being sufficient to return to baseline levels (after ~24 h: 292 ± 21 µmol·L−1).
3.2. Blood Glucose and Serum Insulin
Temporal blood glucose and serum insulin concentrations for the 4 h post prandial period are
displayed in Figure 2A,C. Fasting blood glucose and serum insulin concentrations did not differ
between conditions at baseline (both P > 0.05). For both measures, there was a significant effect of
time (P < 0.0001), such that meal ingestion increased blood glucose and serum insulin concentrations
(peaking at 30 min; glucose: 6.2 ± 0.2 and 6.1 ± 0.2 mmol·L−1, and insulin: 67 ± 10 and 63 ± 8 mU·L−1,
for L-NU and H-NU, respectively) and to a similar degree for both conditions (condition and time
x condition interaction; P > 0.05). Blood glucose iAUC and serum insulin iAUC during the OGTT
(displayed in Figure 2B,D) were also not different between conditions (P > 0.05). Consequently, indirect
peripheral insulin sensitivity calculated using the adapted Cederholm ISI did not differ between
conditions (61 ± 3 and 64 ± 3 mg·L2·mmol−1·mU−1·min−1 for L-NU and H-NU, respectively; P > 0.05).
Nutrients 2020, 12, 1115 6 of 9Nutrients 2020, 12, x FOR PEER REVIEW 6 of 9 
B
0
500
1,000
1,500
0 30 60 90 120 150 180 210 240
0
20
40
60
80
100
Time (mins)
C
Se
ru
m
 in
su
lin
(iA
UC
; m
U.
L-1
 x 
4 h
)
 
Figure 2. Temporal response and incremental area under the curve of blood glucose (A and B) and 
serum insulin (C and D) concentrations during the 4 h post-prandial period following the 
consumption of a nucleotide-depleted (L-NU) or nucleotide-rich (H-NU) mycoprotein-based mixed 
meal in healthy young adults (n = 10). Data were analysed using two-way ANOVAs. Incremental area 
under the curve (iAUC) data were analysed using paired t-tests. Values are means with SEM 
represented by vertical bars. Main effects of time, condition, time x condition interaction and paired 
t-tests (all P > 0.05). 
4. Discussion 
We report that the consumption of a high-nucleotide mixed meal transiently (for 12 h) increased 
serum uric acid concentrations, but did not influence postprandial circulating glucose and insulin 
concentrations, or an adapted Cederholm insulin sensitivity index, compared with the ingestion of a 
low nucleotide control meal in healthy young adults.  
Higher circulating uric acid concentrations are associated with a variety of inflammatory and/or 
metabolic disorders, such as gout [5], hypertension [6], type 2 diabetes [8], and metabolic syndrome 
[7], leading to speculations of a causative role [16]. Dietary nucleotides have been implicated as the 
link between circulating uric acid and such disease progression, since daily short-term (5–9 days) 
ingestion of large quantities (>2 g) (isolated from yeast) has been shown to increase serum uric acid 
concentrations above clinically acceptable thresholds in healthy adults [2,3]. However, it is not clear 
whether this is the case within the context of a more nutritionally relevant mixed meal. Here, we 
report a high-nucleotide containing (i.e., 1.7 g) mixed meal increased serum uric acid concentrations 
within 1 h, and for a duration of 12 h post consumption (see Figure 1). This ~12 % rise (peaking at 319 
µmol.L−1) was transient (returning to near basal levels the following day) and not close to clinically 
significant levels (i.e., ~420 µmol.L−1 in men, ~360 µmol.L−1 in pre-menopausal women [17]) in any of 
the participants. Interestingly, when subdividing our participants based on sex, some differences 
were evident. Namely, in accordance with the literature [17], males displayed higher postabsorptive 
serum uric acid concentrations compared with females, and although the absolute rise following the 
high nucleotide meal was similar between sexes, the higher relative rise amongst females translated 
to a more persistent elevation (i.e., at 24 h). The mechanism by which nucleotide rich meal ingestion 
elevates circulating uric acid concentrations likely relates to increased uric acid production as a 
metabolic end-product without any appreciable increase in (at least over the immediate postprandial 
Figure 2. Temporal response and incremental area under the curve of blood glucose (A,B) and serum
insulin (C,D) concentrations during the 4 h post-prandial period following the consumption of a
nucleotide-depleted (L-NU) or nucleotide-rich (H-NU) mycoprotein-based mixed meal in healthy
young adults (n = 10). Data were analysed using two-way ANOVAs. Incremental area under the curve
(iAUC) data were analysed using paired t-tests. Values are means with SEM represented by vertical
bars. Main effects of time, condition, time x con ition interaction and paired t-tests (all P > 0.05).
4. Discussion
We report that the consumption of a high-nucleotide mixed meal transiently (for 12 h) increased
serum uric acid concentrations, but did not influence postprandial circulating glucose and insulin
concentrations, or an adapted Cederholm insuli sensitivity index, comp red with the ingestion of a
low nucleotide control meal in healthy you g adults.
Higher circulating uric acid concentrations are associated with a variety of inflammatory and/ r
metaboli disorders, such as gout [5], hyperte sion [6], type 2 diabetes [8], and metabolic syndrome [7],
leading to speculatio s of a causative role [16]. Dietary nucleotides hav been implicated as the
link between circulating uric acid and such disease progression, since daily short-term (5–9 ays)
ingestion of large q antities (>2 g) (isolated from yeast) has be n shown to increase serum uric
acid concentrations above clinically cceptable thre holds in healthy adults [2,3]. However, it is not
clear whether this is the case within the context of a more nutritionally relevant mixed meal. Here,
we report high-nucleotide ontaining (i.e., 1.7 g) mixed meal increased serum uric acid concentrations
wit in 1 h, and for a duration of 12 h post c nsu ption (see Figure 1). This ~12 % rise (peaking
at 319 µmol·L−1) was transient (returning to near basal levels the following day) and not close to
clinically significant levels (i.e., ~420 µm l·L−1 in en, ~360 µmol·L−1 in pre-menopausal women [17])
in any of the pa ticipants. Interestingly, when subdividing our participants based on sex, some
differen es wer evident. Na ely, in accordance with the lite atur [17], males displayed higher
postabsorptive serum uric acid concentrations compared with females, and although the absolute
rise following the high nucleotide meal was simila between sexes, the high r relative rise am ngst
females translated to a more persistent elevation (i.e., at 24 h). T e mechanism by which nucleotide
rich meal ingestion levates circulating uric acid concentrations likely r l tes to increased uric acid
pr duction as a metabolic end-product wit out any appreciable increase i (at least over the immediate
postprandial period) urinary clearance. While we did not collect urin samples to onfirm this, recent
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animal data report that experimental alterations in circulating uric acid concentrations are regulated at
the level of renal handling [18]. However, this work also suggested that the direct mechanism was the
level of circulating insulin, which is not consistent with our finding of equivalent postprandial insulin
responses across conditions. Future (intervention) studies are warranted to assess whether repeated
meals result in persistently and cumulatively (i.e., beyond clinically accepted levels) elevated serum
uric acid concentrations, how this affects temporal rates of urinary uric acid clearance and to further
probe the mechanisms underpinning nutritional uric acid balance in health and disease.
Making our current data more striking was the observation that serum uric acid concentrations
decreased (from 45 min to 4 h post meal ingestion) under the control condition. This implies that
the well documented protective effect of some dietary protein sources per se on circulating uric acid
concentrations (shown previously with dairy and some plant based proteins; [19–21]), due to competitive
tubular reabsorption and increased uric acid urinary clearance (either directly or indirectly via greater
urea production), outweighed any impact of the low nucleotide content (i.e., 0.38 g) of this meal. Since
vegan diets have been associated with higher circulating uric acid concentrations [21,22]—proposed
to be attributable to the lack of dairy in the diet—and whilst we did not investigate this, our data
imply nucleotide depleted mycoprotein may be a suitable protein choice to manage uric acid levels in
these populations.
A potential mechanism by which circulating uric acid concentrations may be causative of declining
health status is not clear. Numerous experiments performed in vitro [23–28] have shown that uric
acid is a pro-oxidant in the intracellular environment, implying uric acid may contribute to metabolic
dysfunction by promoting cellular oxidative stress [16]. Here we show that the increase in circulating
uric acid concentrations following the nucleotide rich meal was not associated with any impairment in
postprandial glucose handling or on an insulin sensitivity index. Though only addressing the acute
response to bolus consumption, our data do not support that nutritionally induced acute increases
in circulating uric acid concentrations impair markers of metabolic health. Intervention studies
addressing the impact of habitual (rather than single meal) dietary nucleotide load on circulating
uric acid concentrations and indices of metabolic health will be required to further elucidate the link
between circulating uric acid, cellular oxidative stress, and metabolic health.
5. Conclusions
In conclusion, the ingestion of a nucleotide-rich mixed meal increases serum uric acid concentrations
for ~12 h, but does not influence postprandial blood glucose or serum insulin concentrations.
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